NCT06148233 is a NA clinical trial of [18F]CSF-23 in Positron Emission Tomography, sponsored by Huashan Hospital.

Who is sponsoring NCT06148233?

NCT06148233 is sponsored by Huashan Hospital.

What drugs are being tested in NCT06148233?

Interventions in NCT06148233: [18F]CSF-23.

What condition does NCT06148233 study?

NCT06148233 studies Positron Emission Tomography, Alzheimer Disease, Neurodegenerative Diseases.

Is NCT06148233 still recruiting?

NCT06148233 is currently status unknown. Last updated 28 November 2023.

Last reviewed 2023-11-28 · How we verify

NCT06148233

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging

Status unknown NA Last updated 28 November 2023

What this trial tests

NA trial testing [18F]CSF-23 in Positron Emission Tomography in 40 participants. Status unknown.

Timeline

15 September 2023

Primary endpoint
16 June 2024

14 September 2024

Quick facts

Lead sponsor	Huashan Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	15 September 2023
Primary completion	16 June 2024
Estimated completion	14 September 2024
Sites	1 location across China

Drugs / interventions tested

[18F]CSF-23

Conditions studied

Positron Emission Tomography — all drugs for Positron Emission Tomography →
Alzheimer Disease — all drugs for Alzheimer Disease →
Neurodegenerative Diseases — all drugs for Neurodegenerative Diseases →

Sponsor

Huashan Hospital

Who can join

Adults 60 to 80, any sex, with Positron Emission Tomography or Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the diagnostic value of \[18F\]CSF-23 brain imaging for CSF1R expression in Alzheimer's disease. PET imaging with this PET tracer was used to assess the role and expression of CSF1R in AD and to evaluate the level and safety of abnormal present imaging.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions.
Noh MY, Kwon HS, Kwon MS, Nahm M, et al · · 2025 · cited 24× · PMID 40640892 · DOI 10.1186/s13024-025-00867-4

Verify or expand the search:

Other recruiting trials for Positron Emission Tomography

Currently open trials in the same condition.

NCT06419361 — [68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients · EARLY_PHASE1 · recruiting
NCT05970913 — PET-CT Predicting Lymph Nodes Metastasis · active not recruiting
NCT06827678 — Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging · recruiting
NCT05516732 — Serotonin Release in Premotor and Motor PD · recruiting
NCT06688071 — FAPI PET/CT in Various FAP-Related Disease Patients · recruiting

Other Huashan Hospital trials

Trials by the same sponsor.

NCT07469735 — Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma · NA · not yet recruiting
NCT07364487 — This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis · EARLY_PHASE1 · withdrawn
NCT07369830 — The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function · NA · recruiting
NCT07185373 — Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL · Phase 2, PHASE3 · not yet recruiting
NCT07075029 — RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06148233 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Huashan Hospital
Last refreshed: 28 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06148233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing